Last updated: 2026-09-16 12:18:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
MiMedx Group, Inc. (MDXG) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $4.73, with a market capitalisation of $677.14M and a P/E ratio of 110.40. Over the past 52 weeks, its price has ranged from $3.03 to $7.97. This page covers its latest market performance, valuation, price trends and company information.
$677.14M | |
$4.72 | |
$18.25 | |
$1.81 | |
$4.72 | |
302.00 | |
1.27M | |
110.40 | |
$7.97 | |
$3.03 | |
-- | |
-- |
MiMedx Group, Inc. (MDXG) is trading at $4.73 in pre-market trading as of 2026-09-16 11:37:00, up 0.11% ($0.00) from the previous close of $4.72
Pre-market trading shows how investors are pricing MDXG before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, MiMedx Group, Inc. (MDXG) moved from $4.57 to $4.73, representing a gain of 3.39% ($0.15).
The stock traded between $4.41 and $4.80 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.06 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 34.4%
MDXG is currently trading at $4.73, placing it 34.4% of the way from its 52-week low of $3.03 to its 52-week high of $7.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 808 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of MiMedx Group, Inc. (MDXG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.